aptargroup inc. - ATR
ATR
Close Chg Chg %
145.07 -1.30 -0.90%
Closed Market
143.77
-1.30 (0.90%)
Volume: 390.60K
Last Updated:
Apr 17, 2025, 3:59 PM EDT
Company Overview: aptargroup inc. - ATR
ATR Key Data
| Open $145.59 | Day Range 140.71 - 146.00 |
| 52 Week Range 130.85 - 178.03 | Market Cap $9.49B |
| Shares Outstanding 65.97M | Public Float 65.48M |
| Beta 0.59 | Rev. Per Employee N/A |
| P/E Ratio 26.02 | EPS $5.65 |
| Yield 122.37% | Dividend $0.45 |
| EX-DIVIDEND DATE Feb 5, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 367.68K |
ATR Performance
| 1 Week | -0.19% | ||
| 1 Month | -0.68% | ||
| 3 Months | -7.85% | ||
| 1 Year | 3.22% | ||
| 5 Years | 39.72% |
ATR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
9
Full Ratings ➔
About aptargroup inc. - ATR
AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.
ATR At a Glance
AptarGroup, Inc.
265 Exchange Drive
Crystal Lake, Illinois 60014-9695
| Phone | 1-815-477-0424 | Revenue | 3.58B | |
| Industry | Containers/Packaging | Net Income | 374.54M | |
| Sector | Process Industries | 2024 Sales Growth | 2.737% | |
| Fiscal Year-end | 12 / 2025 | Employees | 13,500 | |
| View SEC Filings |
ATR Valuation
| P/E Current | 26.02 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 28.421 |
| Price to Sales Ratio | 2.968 |
| Price to Book Ratio | 4.226 |
| Price to Cash Flow Ratio | 16.528 |
| Enterprise Value to EBITDA | 14.825 |
| Enterprise Value to Sales | 3.214 |
| Total Debt to Enterprise Value | 0.095 |
ATR Efficiency
| Revenue/Employee | 265,399.259 |
| Income Per Employee | 27,743.778 |
| Receivables Turnover | 5.343 |
| Total Asset Turnover | 0.807 |
ATR Liquidity
| Current Ratio | 1.384 |
| Quick Ratio | 0.952 |
| Cash Ratio | 0.212 |
ATR Profitability
| Gross Margin | 30.471 |
| Operating Margin | 14.315 |
| Pretax Margin | 13.111 |
| Net Margin | 10.454 |
| Return on Assets | 8.432 |
| Return on Equity | 15.675 |
| Return on Total Capital | 10.506 |
| Return on Invested Capital | 11.999 |
ATR Capital Structure
| Total Debt to Total Equity | 44.221 |
| Total Debt to Total Capital | 30.662 |
| Total Debt to Total Assets | 24.662 |
| Long-Term Debt to Equity | 29.847 |
| Long-Term Debt to Total Capital | 20.695 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Aptargroup Inc. - ATR
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 3.23B | 3.32B | 3.49B | 3.58B | |
Sales Growth
| +10.17% | +2.94% | +4.97% | +2.74% | |
Cost of Goods Sold (COGS) incl D&A
| 2.31B | 2.39B | 2.47B | 2.49B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 234.85M | 233.71M | 248.59M | 263.78M | |
Depreciation
| 193.78M | 190.13M | 203.87M | 219.67M | |
Amortization of Intangibles
| 41.07M | 43.57M | 44.72M | 44.12M | |
COGS Growth
| +11.74% | +3.76% | +3.37% | +0.75% | |
Gross Income
| 921.83M | 930.13M | 1.01B | 1.09B | |
Gross Income Growth
| +6.42% | +0.90% | +9.10% | +7.58% | |
Gross Profit Margin
| +28.56% | +28.00% | +29.10% | +30.47% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 534.66M | 549.86M | 551.08M | 578.83M | |
Research & Development
| 99.80M | 93.50M | 92.80M | 96.10M | |
Other SG&A
| 434.86M | 456.36M | 458.28M | 482.73M | |
SGA Growth
| +12.95% | +2.84% | +0.22% | +5.03% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 39.91M | 2.50M | 58.96M | 14.88M | |
EBIT after Unusual Expense
| 347.26M | 377.77M | 404.76M | 498.02M | |
Non Operating Income/Expense
| 4.69M | (2.07M) | 10.48M | 15.64M | |
Non-Operating Interest Income
| 3.67M | 2.70M | 4.37M | 12.10M | |
Equity in Earnings of Affiliates
| (692.00K) | 467.00K | 2.23M | 87.00K | |
Interest Expense
| 30.30M | 41.00M | 40.42M | 43.90M | |
Interest Expense Growth
| -12.73% | +35.32% | -1.41% | +8.61% | |
Gross Interest Expense
| 30.30M | 41.00M | 40.42M | 43.90M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 321.65M | 334.70M | 374.82M | 469.76M | |
Pretax Income Growth
| +6.81% | +4.06% | +11.99% | +25.33% | |
Pretax Margin
| +9.97% | +10.07% | +10.75% | +13.11% | |
Income Tax
| 78.02M | 95.15M | 90.65M | 95.59M | |
Income Tax - Current - Domestic
| 16.85M | 15.06M | 13.08M | 13.68M | |
Income Tax - Current - Foreign
| 75.52M | 92.20M | 97.45M | 103.32M | |
Income Tax - Deferred - Domestic
| (11.17M) | (882.00K) | (11.61M) | (9.86M) | |
Income Tax - Deferred - Foreign
| (3.19M) | (11.22M) | (8.28M) | (11.55M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| (692.00K) | 467.00K | 2.23M | 87.00K | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 243.64M | 239.56M | 284.18M | 374.18M | |
Minority Interest Expense
| (459.00K) | 267.00K | (311.00K) | (363.00K) | |
Net Income
| 244.10M | 239.29M | 284.49M | 374.54M | |
Net Income Growth
| +14.04% | -1.97% | +18.89% | +31.65% | |
Net Margin Growth
| +7.56% | +7.20% | +8.16% | +10.45% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 244.10M | 239.29M | 284.49M | 374.54M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 244.10M | 239.29M | 284.49M | 374.54M | |
EPS (Basic)
| 3.7174 | 3.6587 | 4.3356 | 5.6463 | |
EPS (Basic) Growth
| +11.88% | -1.58% | +18.50% | +30.23% | |
Basic Shares Outstanding
| 65.66M | 65.40M | 65.62M | 66.33M | |
EPS (Diluted)
| 3.5998 | 3.5905 | 4.2475 | 5.5277 | |
EPS (Diluted) Growth
| +12.08% | -0.26% | +18.30% | +30.14% | |
Diluted Shares Outstanding
| 67.68M | 66.72M | 66.91M | 67.69M | |
EBITDA
| 622.02M | 613.98M | 712.32M | 776.68M | |
EBITDA Growth
| +1.44% | -1.29% | +16.02% | +9.04% | |
EBITDA Margin
| +19.27% | +18.48% | +20.43% | +21.68% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 179.60 | |
| Number of Ratings | 9 | Current Quarters Estimate | 1.411 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | 5.577 | |
| Last Quarter’s Earnings | 1.155 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 5.64 | Next Fiscal Year Estimate | 6.252 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 6 | 6 | 6 |
| Mean Estimate | 1.41 | 1.56 | 5.58 | 6.25 |
| High Estimates | 1.44 | 1.62 | 5.75 | 6.43 |
| Low Estimate | 1.36 | 1.51 | 5.40 | 6.03 |
| Coefficient of Variance | 2.13 | 2.71 | 2.02 | 2.41 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 4 |
| OVERWEIGHT | 3 | 2 | 2 |
| HOLD | 1 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Aptargroup Inc. - ATR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Aptargroup Inc. - ATR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 3, 2025 | Gael Touya Segment President | 33,571 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $146.16 per share | 4,906,737.36 |
| Feb 28, 2025 | Hedi Tlili Segment President | 8,986 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $146.23 per share | 1,314,022.78 |
| Feb 27, 2025 | Kimberly Y. Chainey EVP and Chief Legal Officer | 8,437 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Kimberly Y. Chainey EVP and Chief Legal Officer | 7,719 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $147.71 per share | 1,140,173.49 |
| Feb 27, 2025 | Stephan B. Tanda President and CEO; Director | 170,276 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $147.71 per share | 25,151,467.96 |
| Feb 27, 2025 | Stephan B. Tanda President and CEO; Director | 176,637 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Shiela P. Vinczeller Chief Human Resources Officer | 23,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Shiela P. Vinczeller Chief Human Resources Officer | 22,022 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $147.71 per share | 3,252,869.62 |
| Feb 26, 2025 | Xiang Wei Gong President, Asia | 12,518 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $145.61 per share | 1,822,745.98 |
| May 8, 2024 | Marc Prieur Segment President | 16,616 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $148.92 per share | 2,474,454.72 |
| May 3, 2024 | Julie Xing Director | 2,696 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | George L. Fotiades Director | 6,075 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | Sarah Glickman Director | 2,007 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | Matthew L. Trerotola Director | 6,761 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | Isabel Marey-Semper Director | 7,275 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | Ralf Klaus Wunderlich Director | 16,144 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | B. Craig Owens Director | 8,688 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | Giovanna Kampouri Monnas Director | 10,761 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 3, 2024 | Candace Sheffield Matthews Director | 5,070 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2024 | Hedi Jallel Tlili Segment President | 12,546 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $74.79 per share | 938,315.34 |